{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T21:58:57Z","timestamp":1761170337485,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T00:00:00Z","timestamp":1544572800000},"content-version":"vor","delay-in-days":102,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hellenic Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.hjc.2018.12.001","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T03:45:35Z","timestamp":1545277535000},"page":"279-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel therapeutic options in the prevention of atrial fibrillation"],"prefix":"10.1016","volume":"59","author":[{"given":"Stefanos","family":"Archontakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skevos","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hjc.2018.12.001_bib1","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1161\/CIRCRESAHA.114.302362","article-title":"Atrial fibrillation therapy now and in the future. Drugs, biologicals, and ablation","volume":"114","author":"Woods","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.hjc.2018.12.001_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0008-6363(02)00243-2","article-title":"Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure","volume":"54","author":"Shi","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hjc.2018.12.001_bib3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0735-1097(03)00464-9","article-title":"Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation","volume":"41","author":"Kumagai","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib4","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.jacc.2004.11.070","article-title":"Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis","volume":"45","author":"Healey","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/pace.13169","article-title":"Eplerenone might affect atrial fibrosis in patients with hypertension","volume":"40","author":"Kawasaki","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib6","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.jacc.2010.01.043","article-title":"Prevention of atrial fibrillation by renin-angiotensin system inhibition: A metanalysis","volume":"55","author":"Schneider","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib7","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa0805710","article-title":"Valsartan for prevention of recurrent atrial fibrillation","volume":"360","author":"Disertori","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hjc.2018.12.001_bib8","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1161\/01.CIR.0000145163.56529.D1","article-title":"Effect of simvastatin and antioxidant vitamins on atrial fibrillation promotion by atrial- tachycardia remodeling in dogs","volume":"110","author":"Shiroshita-Takeshita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2018.12.001_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/HCO.0b013e32835b0956","article-title":"Statin therapy and atrial fibrillation: systematic review and updated meta-analysis of published randomized controlled trials","volume":"28","author":"Fauchier","year":"2013","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib10","article-title":"Atorvastatin prevents postoperative atrial fibrillation in patients undergoing cardiac surgery","author":"Sai","year":"2018","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib11","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jacc.2007.09.063","article-title":"Antiarrhythmic effects of statin therapy and atrial fibrillation. A meta-analysis of randomised controlled trials","volume":"51","author":"Fauchier","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib12","first-page":"1","article-title":"Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: Review of evidence and clinical relevance","volume":"381","author":"Savelieva","year":"2010","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.hjc.2018.12.001_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186972","article-title":"Statins and new-onset atrial fibrillation in a cohort of patients with hypertension. Analysis of electronic health records, 2006\u20132015","volume":"12","author":"Alves-Cabratosa","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.hjc.2018.12.001_bib14","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1161\/CIRCULATIONAHA.106.624320","article-title":"Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure","volume":"114","author":"Lee","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2018.12.001_bib15","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s12872-017-0531-4","article-title":"Thiazolidinedione use and atrial fibrillation in diabetic patients: a meta-analysis","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.hjc.2018.12.001_bib16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacbts.2016.03.003","article-title":"Galectin-3 regulates atrial fibrillation remodeling and predicts catheter ablation outcomes","volume":"1","author":"Takemoto","year":"2016","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.hjc.2018.12.001_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.hjc.2017.01.025","article-title":"PPAR\u03b3 agonist use and recurrence of atrial fibrillation after successful electrical cardioversion","volume":"58","author":"Gu","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.hjc.2018.02.009","article-title":"Effects of Guanfu total base on Bcl-2 and Bax expression and correlation with atrial fibrillation","volume":"59","author":"Li","year":"2018","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib19","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/CIRCULATIONAHA.116.023163","article-title":"Modifiable risk factors and atrial fibrillation","volume":"136","author":"Lau","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.hjc.2018.12.001_bib20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15420\/aer.2018.18.2","article-title":"Risk factor management in atrial fibrillation","volume":"7","author":"Brandes","year":"2018","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"10.1016\/j.hjc.2018.12.001_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.hjc.2017.03.001","article-title":"Characteristics of coronary artery disease among patients with atrial fibrillation compared to patients with sinus rhythm","volume":"58","author":"Motloch","year":"2017","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.hjc.2018.12.001_bib22","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"32","key":"10.1016\/j.hjc.2018.12.001_bib23","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hjc.2018.12.001_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.hjc.2016.11.003","article-title":"The role of novel oral anticoagulants in patients undergoing cryoballoon ablation for atrial fibrillation","volume":"57","author":"Baltogiannis","year":"2016","journal-title":"Hellenic J Cardiol"}],"container-title":["Hellenic Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966618305219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1109966618305219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:11:49Z","timestamp":1761099109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1109966618305219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1109966618305219"],"URL":"https:\/\/doi.org\/10.1016\/j.hjc.2018.12.001","relation":{},"ISSN":["1109-9666"],"issn-type":[{"type":"print","value":"1109-9666"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel therapeutic options in the prevention of atrial fibrillation","name":"articletitle","label":"Article Title"},{"value":"Hellenic Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hjc.2018.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Hellenic Society of Cardiology. Publishing services by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}